Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 7423.89 | 89 / 89 | 98% | 54.42 | 886 / 901 |
pancreas | 100% | 3295.02 | 328 / 328 | 96% | 38.78 | 171 / 178 |
lung | 98% | 3226.27 | 566 / 578 | 96% | 46.48 | 1108 / 1155 |
prostate | 92% | 5196.51 | 226 / 245 | 100% | 96.80 | 502 / 502 |
thymus | 100% | 8455.35 | 653 / 653 | 92% | 64.91 | 556 / 605 |
liver | 100% | 3777.46 | 226 / 226 | 87% | 22.12 | 353 / 406 |
breast | 85% | 2234.78 | 389 / 459 | 98% | 61.59 | 1097 / 1118 |
stomach | 76% | 5543.74 | 274 / 359 | 99% | 68.16 | 283 / 286 |
intestine | 54% | 4995.88 | 526 / 966 | 99% | 61.58 | 522 / 527 |
bladder | 52% | 1311.43 | 11 / 21 | 91% | 35.00 | 460 / 504 |
esophagus | 41% | 3022.31 | 592 / 1445 | 98% | 68.99 | 180 / 183 |
adrenal gland | 100% | 10788.49 | 258 / 258 | 38% | 14.86 | 87 / 230 |
ovary | 24% | 266.77 | 43 / 180 | 96% | 39.74 | 412 / 430 |
spleen | 100% | 2956.44 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 22.08 | 1 / 1 |
tonsil | 0% | 0 | 0 / 0 | 89% | 28.41 | 40 / 45 |
uterus | 7% | 151.12 | 12 / 170 | 81% | 27.54 | 374 / 459 |
peripheral blood | 86% | 3706.03 | 801 / 929 | 0% | 0 | 0 / 0 |
skin | 70% | 1255.27 | 1275 / 1809 | 11% | 1.76 | 52 / 472 |
adipose | 75% | 1108.63 | 897 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 59% | 11.22 | 17 / 29 |
blood vessel | 11% | 126.96 | 143 / 1335 | 0% | 0 | 0 / 0 |
brain | 1% | 9.06 | 24 / 2642 | 10% | 1.46 | 67 / 705 |
heart | 3% | 27.07 | 24 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 3% | 0.40 | 2 / 80 |
muscle | 0% | 1.26 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0002244 | Biological process | hematopoietic progenitor cell differentiation |
GO_0016554 | Biological process | cytidine to uridine editing |
GO_0008380 | Biological process | RNA splicing |
GO_0006397 | Biological process | mRNA processing |
GO_0032733 | Biological process | positive regulation of interleukin-10 production |
GO_0060340 | Biological process | positive regulation of type I interferon-mediated signaling pathway |
GO_0000381 | Biological process | regulation of alternative mRNA splicing, via spliceosome |
GO_0070935 | Biological process | 3'-UTR-mediated mRNA stabilization |
GO_0030895 | Cellular component | apolipoprotein B mRNA editing enzyme complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0140767 | Molecular function | enzyme-substrate adaptor activity |
GO_0019899 | Molecular function | enzyme binding |
GO_0003730 | Molecular function | mRNA 3'-UTR binding |
GO_0005515 | Molecular function | protein binding |
GO_0003729 | Molecular function | mRNA binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | RBM47 |
Protein name | RNA-binding protein 47 (RNA-binding motif protein 47) RNA binding motif protein 47 |
Synonyms | |
Description | FUNCTION: Single-stranded RNA-binding protein that functions in a variety of RNA processes, including alternative splicing, RNA stabilization, and RNA editing . Functions as an enzyme-substrate adapter for the cytidine deaminase APOBEC1. With APOBEC1 forms an mRNA editing complex involved into cytidine to uridine editing of a variety of mRNA molecules . Through the binding of their 3'UTR, also stabilizes a variety of mRNAs and regulates the expression of genes such as the interferon alpha/beta receptor and interleukin-10 . Also involved in the alternative splicing of several genes including TJP1. Binds the pre-mRNA (U)GCAUG consensus sequences in downstream intronic regions of alternative exons, regulating their exclusion and inclusion into mRNAs . Independently of its RNA-binding activity, could negatively regulate MAVS by promoting its lysosomal degradation (By similarity). . |
Accessions | D6RBS9 B7Z8Z7 B7ZLP7 ENST00000507180.5 ENST00000510871.5 D6RBP6 ENST00000295971.12 [A0AV96-1] ENST00000514014.1 ENST00000514782.5 ENST00000381793.6 [A0AV96-1] D6R9D6 ENST00000381795.10 [A0AV96-2] A0AV96 ENST00000505414.5 ENST00000511598.5 D6R9M7 D6RCT1 ENST00000513473.5 D6RA49 ENST00000515053.5 ENST00000511902.5 ENST00000505220.1 D6REZ6 D6RFL5 |